Member Exclusive

Chronic heart failure clinical trial: mesenchymal stem cell therapy safety & viability reported

A Phase IIa clinical trial utilizing intravenous administration of mesenchymal stem cells in cardiac patients has reported positive safety and efficacy results.

Thumb rme journal large
Sep 02, 2016
0
0

Please sign in or register for FREE

No comments yet.